Identification of myeloma high-risk subclones with single-cell technologies

Identification of myeloma high-risk subclones with single-cell technologies

Novel technologies and the prognostic value of identifying subclones in myelomaПодробнее

Novel technologies and the prognostic value of identifying subclones in myeloma

Subclonal evolution and cytogenetic aberrations in myelomaПодробнее

Subclonal evolution and cytogenetic aberrations in myeloma

Single Cell Analysis | Gareth Morgan, MD, PhD | IMS 2022Подробнее

Single Cell Analysis | Gareth Morgan, MD, PhD | IMS 2022

Using single-cell analysis to tackle myelomaПодробнее

Using single-cell analysis to tackle myeloma

Single-Cell Identification of SMM Clones Driving Myeloma Progression and Therapy ResistanceПодробнее

Single-Cell Identification of SMM Clones Driving Myeloma Progression and Therapy Resistance

CTC whole-genome sequencing vs FISH to monitor the emergence of multiple myeloma high-risk subclonesПодробнее

CTC whole-genome sequencing vs FISH to monitor the emergence of multiple myeloma high-risk subclones

Identifying high-risk multiple myeloma patient subgroups using genetic and clinical factorsПодробнее

Identifying high-risk multiple myeloma patient subgroups using genetic and clinical factors

Approaches to risk stratification in high risk myelomaПодробнее

Approaches to risk stratification in high risk myeloma

The use of single-cell RNA sequencing to identify mechanisms of drug resistance in multiple myelomaПодробнее

The use of single-cell RNA sequencing to identify mechanisms of drug resistance in multiple myeloma

From Cells to Cures: Advancing Clonal Profiling in Leukemia & Myeloma with Single-Cell Multi-omicsПодробнее

From Cells to Cures: Advancing Clonal Profiling in Leukemia & Myeloma with Single-Cell Multi-omics

Single-cell multiomics analysis and the role of PHF19 expression in high-risk multiple myelomaПодробнее

Single-cell multiomics analysis and the role of PHF19 expression in high-risk multiple myeloma

Identification of a T-cell population associated with outcomes in myeloma with t(4;14) translocationПодробнее

Identification of a T-cell population associated with outcomes in myeloma with t(4;14) translocation

Using single-cell RNA-sequencing to identify biomarkers of progression in patients with SMMПодробнее

Using single-cell RNA-sequencing to identify biomarkers of progression in patients with SMM

Improving the identification of patients with high-risk multiple myelomaПодробнее

Improving the identification of patients with high-risk multiple myeloma

Single cell Sequencing | Romanos Sklavenitis-Pistofidis, MD | IMS 2022Подробнее

Single cell Sequencing | Romanos Sklavenitis-Pistofidis, MD | IMS 2022

Single-cell RNA sequencing of BM and PB samples from patients with high-risk smoldering myelomaПодробнее

Single-cell RNA sequencing of BM and PB samples from patients with high-risk smoldering myeloma

How to Better Diagnose Patients With High-Risk Myeloma | Martin Kaiser, MD | ASH 2022Подробнее

How to Better Diagnose Patients With High-Risk Myeloma | Martin Kaiser, MD | ASH 2022

Single Cell RNA Sequencing and Multiple Myeloma | Nicholas BanovichПодробнее

Single Cell RNA Sequencing and Multiple Myeloma | Nicholas Banovich

The importance of accurately defining high-risk myeloma and current risk stratification systemsПодробнее

The importance of accurately defining high-risk myeloma and current risk stratification systems

События